μCollaFibR™ Additive for Bioinks and Hydrogels

3DBioFibR Inc.

Halifax, NS, Canada

3DBioFibR is a biomaterial manufacturing company pioneering the future of regenerative medicine with the world s first commercially scalable collagen fibers and other high-value biopolymers such as chitosan and spider silk . Using our patent-issued dry-spinning technology , we can produce fibers that faithfully recapitulate the natural biomechanical strength and biochemical complexity of native structures—at 3,600x the scale of traditional methods . Our fully automated, high-throughput manufacturing system ensures consistency and scalability, enabling us to transform how collagen and other biopolymers are used across industries. We deliver these materials through two central form factors : Non-woven scaffolds with proven applications in tissue engineering and 3D cell culture . Multifilament yarns , which have garnered significant traction in sutures, hernia meshes, and other surgical materials . Both form factors can be further tuned to incorporate active pharmaceutical ingredients (APIs) , allowing for timed drug release as fibers degrade. This versatility expands their impact across the biomedical landscape, including 3D bioprinting additives, hydrogel reinforcement, wound care, orthopedics, and regenerative medicine . By bridging nature s blueprint with industrial scalability , 3DBioFibR is not simply supplying biomaterials—we are enabling the next generation of medical and biotechnological innovations , already validated through partnerships with major players in the field.